Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02ITL
|
||||
Former ID |
DIB008201
|
||||
Drug Name |
AV-201
|
||||
Synonyms |
AAV (amino acid decarboxylase), Avigen; AAV (tyrosine hydroxylase), Avigen; AAV gene therapy (Parkinsons), Avigen; AAV vector (AADC), Avigen; AAV vector (TH), Avigen; AAV-hAADC-2; Gene therapy (PD), Avigen; Gene therapy (Parkinsons disease), Avigen; Gene therapy (L-aromatic amino acid decarboxylase), Avigen
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 2 | [551892] | ||
Company |
Avigen Inc
|
||||
Target and Pathway | |||||
Target(s) | Aromatic-L-amino-acid decarboxylase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.